Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R McGill

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine|November 13, 2020
A multifunctional nanoparticle as a prophylactic and therapeutic approach targeting respiratory syncytial virusEleni Markoutsa, Andrew R McGill, Anthony Singer, et al.
Cancers|June 2, 2021
SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal CancerMark C Howell, Ryan Green, Andrew R McGill, et al.
Infectious Disease Reports|February 9, 2021
SARS-CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and ChallengesAndrew R McGill, Roukiah Kahlil, Rinku Dutta, et al.
Viruses|July 29, 2023
Acetate-encapsulated Linolenic Acid Liposomes Reduce SARS-CoV-2 and RSV InfectionAndrew R McGill, Eleni Markoutsa, Karthick Mayilsamy, et al.
Frontiers in Immunology|December 13, 2021
Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the LungsMark C Howell, Ryan Green, Andrew R McGill, et al.
Molecular Therapy. Methods & Clinical Development|October 3, 2022
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease riskRyan Green, Karthick Mayilsamy, Andrew R McGill, et al.
Viruses|March 26, 2022
Identification of SARS-CoV-2 Spike Palmitoylation Inhibitors That Results in Release of Attenuated Virus with Reduced InfectivityAhmed A Ramadan, Karthick Mayilsamy, Andrew R McGill, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
Targeting an evolutionarily conserved "E-L-L" motif in the spike protein to develop a small molecule fusion inhibitor against SARS-CoV-2Indrani Das Jana, Prabuddha Bhattacharya, Karthick Mayilsamy, et al.
PNAS Nexus|January 30, 2023
Targeting an evolutionarily conserved "E-L-L" motif in spike protein to identify a small molecule fusion inhibitor against SARS-CoV-2Indrani Das Jana, Prabuddha Bhattacharya, Karthick Mayilsamy, et al.
Applied Sciences (Basel, Switzerland)|March 15, 2024
Advances in Translational Nanotechnology: Challenges and OpportunitiesShyam S Mohapatra, Robert D Frisina, Subhra Mohapatra, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nanomedicine : Nanotechnology, Biology, and Medicine|November 13, 2020
A multifunctional nanoparticle as a prophylactic and therapeutic approach targeting respiratory syncytial virusEleni Markoutsa, Andrew R McGill, Anthony Singer, et al.
Cancers|June 2, 2021
SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal CancerMark C Howell, Ryan Green, Andrew R McGill, et al.
Infectious Disease Reports|February 9, 2021
SARS-CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and ChallengesAndrew R McGill, Roukiah Kahlil, Rinku Dutta, et al.
Viruses|July 29, 2023
Acetate-encapsulated Linolenic Acid Liposomes Reduce SARS-CoV-2 and RSV InfectionAndrew R McGill, Eleni Markoutsa, Karthick Mayilsamy, et al.
Frontiers in Immunology|December 13, 2021
Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the LungsMark C Howell, Ryan Green, Andrew R McGill, et al.
Molecular Therapy. Methods & Clinical Development|October 3, 2022
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease riskRyan Green, Karthick Mayilsamy, Andrew R McGill, et al.
Viruses|March 26, 2022
Identification of SARS-CoV-2 Spike Palmitoylation Inhibitors That Results in Release of Attenuated Virus with Reduced InfectivityAhmed A Ramadan, Karthick Mayilsamy, Andrew R McGill, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
Targeting an evolutionarily conserved "E-L-L" motif in the spike protein to develop a small molecule fusion inhibitor against SARS-CoV-2Indrani Das Jana, Prabuddha Bhattacharya, Karthick Mayilsamy, et al.
PNAS Nexus|January 30, 2023
Targeting an evolutionarily conserved "E-L-L" motif in spike protein to identify a small molecule fusion inhibitor against SARS-CoV-2Indrani Das Jana, Prabuddha Bhattacharya, Karthick Mayilsamy, et al.
Applied Sciences (Basel, Switzerland)|March 15, 2024
Advances in Translational Nanotechnology: Challenges and OpportunitiesShyam S Mohapatra, Robert D Frisina, Subhra Mohapatra, et al.
Pageof 1